Conditions: Membranous Nephropathy; MN
Interventions: Drug: Belimumab; Drug: Placebo for Belimumab; Drug: Rituximab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Belimumab With Rituximab for Primary Membranous Nephropathy
May 14, 2019ClinicalTrials.govComments OffNephrologyBelimumab | Membranous | Nephropathy | Primary | Rituximab
Comments




